Kali, Inc.
$0.00+0.00%(+$0.00)
TickerSpark Score
52/100
80
Valuation
70
Profitability
60
Growth
20
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KALY research report →
52-Week Range0% of range
Low $0.00
Current $0.00
High $0.00
Companywww.kali-extracts.com
Kali, Inc. , doing business as Kali-Extracts, Inc. , engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses.
- CEO
- Frederick Ferri
- IPO
- 2008
- Employees
- 171
- HQ
- Dallas, TX, US
Price Chart
-98.00% · this period
Valuation
- Market Cap
- $50.91K
- P/E
- -4.28
- P/S
- 0.78
- P/B
- -0.09
- EV/EBITDA
- -49.94
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 22.01%
- Op Margin
- -18.23%
- Net Margin
- -18.24%
- ROE
- 3.26%
- ROIC
- 436.86%
Growth & Income
- Revenue
- $65.27K · -3.44%
- Net Income
- $-11,903 · -27.85%
- EPS
- $-0.00 · 26.26%
- Op Income
- $-11,900
- FCF YoY
- 97.34%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -72.35
- Avg Volume
- 60.81K
Get TickerSpark's AI analysis on KALY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our KALY Coverage
We haven't published any research on KALY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KALY Report →Similar Companies
ACUR+0.00%
Acura Pharmaceuticals, Inc.
$0.00
FLHLF+0.00%
Filament Health Corp.
$0.00
CBDX+0.00%
Curative Biosciences, Inc.
$0.00
TNPH+0.00%
Tian'an Pharmaceutical Co., Ltd.
$0.01
AZFL+0.00%
Amazonas Florestal, Ltd
$0.00
CNNC+0.00%
Cannonau Corp.
$0.00
NNRX+0.00%
Nutranomics, Inc.
$0.00
MRRCF+0.00%
Wayland Group Corp.
$0.00